VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
BURGER, JAN ANDREAS
One or more keywords matched the following items that are connected to
BURGER, JAN ANDREAS
Item Type
Name
Concept
Immunoglobulin A
Concept
Immunoglobulin Heavy Chains
Concept
Immunoglobulin Isotypes
Concept
Immunoglobulin Variable Region
Concept
Immunoglobulin D
Concept
Immunoglobulin M
Academic Article
Extramedullary plasmocytoma with local amyloidosis presenting as a lump on the lip.
Academic Article
Multivariable model for time to first treatment in patients with chronic lymphocytic leukemia.
Academic Article
Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy.
Academic Article
Functional differences between IgM and IgD signaling in chronic lymphocytic leukemia
Academic Article
?2 -microglobulin normalization within 6 months of ibrutinib-based treatment is associated with superior progression-free survival in patients with chronic lymphocytic leukemia.
Academic Article
Functional Differences between IgM and IgD Signaling in Chronic Lymphocytic Leukemia.
Academic Article
The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab.
Academic Article
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia.
Academic Article
Going through Changes: Surface IgM Levels during CLL Therapy with Ibrutinib.
Academic Article
The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia.
Academic Article
Treatment algorithm for Japanese patients with chronic lymphocytic leukemia in the era of novel targeted therapies.
Academic Article
Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations.
Academic Article
RPPA-based proteomics recognizes distinct epigenetic signatures in chronic lymphocytic leukemia with clinical consequences.
Academic Article
B cell receptor isotypes differentially associate with cell signaling, kinetics, and outcome in chronic lymphocytic leukemia.
Academic Article
Molecular map of chronic lymphocytic leukemia and its impact on outcome.
Search Criteria
Immunoglobulin D